Trial (year) | Location | Design | NPC 30-bp del-LMP1 EBV | XhoI-loss LMP1 EBV | Control group | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  | Present | Not present | Type of sample | Present | Not present | Type of sample | N | Type of sample | Type of control |
Senyuta et al. 2014 [35] | Russia | Case–control | 4 | 18 | Biopsy |  |  |  | 15 | PBMC | HD |
Gurtsevitch et al. 2013 [36] | Russia | Case–control | 3 | 18 | Biopsy |  |  |  | 13 | PBMC | Non-NPC |
Banko et al. 2012 [37] | Serbia | Case–control | 1 | 15 | Biopsy |  |  |  | 30 | PBMC | IM |
Li et al. 2009 [38] | China | Case–control | 43 | 7 | Biopsy |  |  |  | 56 | PBMC | HD |
See et al. 2008 [39] | Malaysia | Case–control | 19 | 15 | Biopsy | 34 | 5 | Biopsy | 8 | Biopsy | Non-NPC |
Tang et al. 2008 [40] | China | Cohort | 18 | 3 | Biopsy | 21 | 0 | Biopsy | Â | Â | Â |
Tiwawech et al. 2008 [41] | Thailand | Case–control | 44 | 31 | PBL |  |  |  | 44 | PBMC | Non-NPC/HD |
Ayadi et al. 2007 [42] | Tunisia | Cohort | 41 | 6 | Biopsy | 0 | 47 | Biopsy | Â | Â | Â |
Chang et al. 2006 [43] | Taiwan | Cohort | 446 | 88 | Biopsy | Â | Â | Â | Â | Â | Â |
Dardari et al. 2006 [44] | Morocco | Case–control | 51 | 10 | Biopsy |  |  |  | 17 | PBMC | HD |
Chabay et al. 2004 [45] | Argentina | Case–control | 3 | 1 | Biopsy |  |  |  | 15 | Biopsy/PBMC | Non-NPC |
Min et al. 2004 [46] | China | Case–control | 87 | 12 | Biopsy |  |  |  | 46 | PBMC | HD |
Nurhantari et al. 2003 [47] | Indonesia | Cohort | 22 | 33 | Biopsy | Â | Â | Â | Â | Â | Â |
Plaza et al. 2003 [48] | Spain | Case–control | 18 | 9 | Biopsy |  |  |  | 40 | - | EBV-RC |
Tan et al. 2003 [49] | Malaysia | Case–control | 25 | 0 | Biopsy | 25 | 2 | Biopsy | 12 | Biopsy |  |
Zhang et al. 2002 [50] | China | Case–control | 36 | 7 | Biopsy |  |  |  | 36 | TW | HD |
Hahn et al. 2001 [51] | Russia | Case–control | 0 | 7 | Biopsy |  |  |  | 10 | PBMC | HD |
Henry et al. 2001 [52] | Tunisia | Cohort | 3 | 3 | Biopsy | 0 | 6 | Biopsy | Â | Â | Â |
Kuo et al. 2001 [53] | Taiwan | Cohort | 2 | 0 | Biopsy | Â | Â | Â | Â | Â | Â |
D’Addario et al. 2000 [54] | Canada | Cohort | 9 | 14 | Biopsy |  |  |  |  |  |  |
Cheung et al. 1998 [55] | China | Cohort | 34 | 3 | Biopsy | Â | Â | Â | Â | Â | Â |
Grunewald et al. 1998 [56] | Multicenter | Case–control | 46 | 18 | Biopsy |  |  |  | 45 | PBMC | HD |
Sung et al. 1998 [57] | China | Cohort | 30 | 12 | Biopsy | 22 | 6 | Biopsy | Â | Â | Â |
Cheung et al. 1996 [58] | China | Case–control | 69 | 5 | Biopsy | 5 | 0 | Biopsy | 11 | Biopsy | Non-NPC |
Khanim et al. 1996 [29] | Multicenter | Case–control | 24 | 4 | Biopsy | 19 | 9 | Biopsy | 14 | Biopsy/PBMC | Non-NPC |
Chang et al. 1995 [59] | Taiwan | Case–control |  |  |  | 48 | 0 | Biopsy | 25 | Biopsy/TW | HD |
Bouzid et al. 1994 [60] | North Africa | Cohort | Â | Â | Â | 1 | 12 | Biopsy | Â | Â | Â |
Jeng et al. 1994 [61] | Taiwan | Case–control |  |  |  | 25 | 7 | Biopsy | 79 |  | Non-NPC |
Miller et al. 1994 [62] | Multicenter | Cohort | 9 | 4 | Biopsy | Â | Â | Â | Â | Â | Â |
Abdel-Hamid et al. 1992 [63] | Multicenter | Case–control |  |  |  | 33 | 18 | Biopsy | 19 | - | Non-NPC |
Hu et al. 1991 [64] | Multicenter | Cohort | Â | Â | Â | 38 | 18 | Biopsy | Â | Â | Â |